Cohance Lifesciences Limited (NSE:COHANCE)
India · Delayed Price · Currency is INR 1,064.90
-5.75 (-0.54%)
Jul 22, 2025, 3:30 PM IST
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 409.60 billion as of July 22, 2025. Its market cap has increased by 95.09% in one year.
Market Cap
409.60B
Enterprise Value
411.02B
Revenue
11.98B
Ranking
n/a
PE Ratio
102.45
Stock Price
1,064.90
Market Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 409.60B, an increase of 1,215,136.64%. That is a compound annual growth rate of 476.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2025 | 409.60B | 41.30% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | 115.14B | 341,510.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,063.51B |
| Divi's Laboratories | 1,787.00B |
| Cipla | 1,197.33B |
| Mankind Pharma | 1,094.68B |
| Apollo Hospitals Enterprise | 1,043.09B |
| Zydus Lifesciences | 981.03B |
| Aurobindo Pharma | 661.82B |
| Glenmark Pharmaceuticals | 628.04B |